Effect of intensive lipid lowering on progression of coronary atherosclerosis: evidence for an early benefit from the Reversal of Atherosclerosis with Aggressive Lipid …
SE Nissen - The American journal of cardiology, 2005 - Elsevier
Statins reduce both atherogenic lipoproteins and high-sensitivity C-reactive protein
(hsCRP). The optimal strategy for administration of lipid-lowering agents has evolved …
(hsCRP). The optimal strategy for administration of lipid-lowering agents has evolved …
Effect of Intensive Lipid Lowering on Progression of Coronary Atherosclerosis: Evidence for an Early Benefit from the Reversal of Atherosclerosis with Aggressive Lipid …
SE Nissen - The American Journal of Cardiology, 2005 - infona.pl
Statins reduce both atherogenic lipoproteins and high-sensitivity C-reactive protein
(hsCRP). The optimal strategy for administration of lipid-lowering agents has evolved …
(hsCRP). The optimal strategy for administration of lipid-lowering agents has evolved …
Effect of intensive lipid lowering on progression of coronary atherosclerosis: evidence for an early benefit from the Reversal of Atherosclerosis with Aggressive Lipid …
SE Nissen - The American Journal of Cardiology, 2005 - europepmc.org
Statins reduce both atherogenic lipoproteins and high-sensitivity C-reactive protein
(hsCRP). The optimal strategy for administration of lipid-lowering agents has evolved …
(hsCRP). The optimal strategy for administration of lipid-lowering agents has evolved …
[引用][C] Effect of intensive lipid lowering on progression of coronary atherosclerosis: Evidence for an early benefit from the reversal of atherosclerosis with aggressive …
SE NISSEN - The American journal of cardiology, 2005 - pascal-francis.inist.fr
Effect of intensive lipid lowering on progression of coronary atherosclerosis : Evidence for
an early benefit from the reversal of atherosclerosis with aggressive lipid lowering (REVERSAL) …
an early benefit from the reversal of atherosclerosis with aggressive lipid lowering (REVERSAL) …
Effect of intensive lipid lowering on progression of coronary atherosclerosis: evidence for an early benefit from the Reversal of Atherosclerosis with Aggressive Lipid …
SE Nissen - The American journal of cardiology, 2005 - pubmed.ncbi.nlm.nih.gov
Statins reduce both atherogenic lipoproteins and high-sensitivity C-reactive protein
(hsCRP). The optimal strategy for administration of lipid-lowering agents has evolved …
(hsCRP). The optimal strategy for administration of lipid-lowering agents has evolved …
Effect of Intensive Lipid Lowering on Progression of Coronary Atherosclerosis: Evidence for an Early Benefit from the Reversal of Atherosclerosis with Aggressive Lipid …
SE Nissen - American Journal of Cardiology, 2005 - ajconline.org
Statins reduce both atherogenic lipoproteins and high-sensitivity C-reactive protein
(hsCRP). The optimal strategy for administration of lipid-lowering agents has evolved …
(hsCRP). The optimal strategy for administration of lipid-lowering agents has evolved …
[引用][C] Effect of Intensive Lipid Lowering on Progression of Coronary Atherosclerosis: Evidence for an Early Benefit from the Reversal of Atherosclerosis with …
SE Nissen - The American Journal of Cardiology, 2005 - cir.nii.ac.jp
Effect of Intensive Lipid Lowering on Progression of Coronary Atherosclerosis: Evidence for an
Early Benefit from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) …
Early Benefit from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) …